STOCK TITAN

Ecarx Holdings (ECXWW) Financials

ECXWW
FY2025 annual
Revenue $847.9M +9.9% YoY
Net Income -$66.0M +49.1% YoY
EPS (Diluted) -$0.20 +48.7% YoY
Free Cash Flow -$106.6M -40.4% YoY
Source SEC Filings (10-K/10-Q) Latest period FY2025, ended Dec 31, 2025 Reported Currency USD FYE December

Newest figures come from the 10-K for FY2025, filed Mar 30, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the ECXWW SEC filings page.

Ecarx Holdings (ECXWW) reported $847.9M in revenue for fiscal year 2025, up 9.9% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 4 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI ECXWW FY2025

Revenue scale is improving operating losses, but gross-margin compression and financing dependence keep cash conversion fragile.

By FY2025, operating margin reached -6.5% while gross margin fell to 19.0%, indicating expense discipline and cost absorption—not improved gross economics—drove the narrower loss. In FY2025, operating cash flow was -$94.4M versus free cash flow of -$106.6M; investing outlays therefore widened the cash gap, so the accounting improvement has not yet produced self-funding operations.

FY2025 liabilities of $945.9M exceeded assets of $662.4M, leaving negative equity of -$282.7M and showing a balance sheet financed more heavily by obligations than owned capital. A current ratio of 0.6x also indicates that short-term resources remained below short-term claims.

R&D declined from $175.6M in FY2022 to $123.3M in FY2025 while revenue expanded, suggesting spending was moderated as the business scaled. Yet FY2025 financing cash inflow of $203.9M was more than twice the operating cash outflow, revealing that external financing—not operations—bridged the cash requirement.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Financial health score not available

Ecarx Holdings does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Piotroski F-Score Partial
2/7

Ecarx Holdings passes 2 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 1 of 4 profitability signals pass, all 1 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality No Cash Backing
N/A

Ecarx Holdings reported a net loss of $66.0M while operations used $94.4M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Interest Coverage At Risk
N/A

Ecarx Holdings reported an operating loss of $54.8M against $23.8M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

None of these metrics is reported for Q4 2025.

Cash & Balance Sheet

Cash & Debt
$87.1M
YoY+96.9%
QoQ+1.0%

Ecarx Holdings held $87.1M in cash as of Q4 2025; long-term debt is not reported for that period.

Free Cash Flow

Not reported for Q4 2025.

Dividends Per Share

Not reported for Q4 2025.

Shares Outstanding

Not reported for Q4 2025.

Margins & Returns

None of these metrics is reported for Q4 2025.

Capital Allocation

None of these metrics is reported for Q4 2025.

ECXWW Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

ECXWW quarterly income statement
MetricQ4'2510-KQ2'2510-QQ4'2410-KQ2'2410-QQ4'2310-KQ4'2210-K

Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, Operating Income, EBITDA, Interest Expense, Income Tax, Net Income, EPS (Basic), EPS (Diluted), Diluted Shares (Avg).

ECXWW Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

ECXWW quarterly balance sheet
MetricQ4'2510-KQ2'2510-QQ4'2410-KQ2'2410-QQ4'2310-KQ4'2210-K
Total Assets$662.4M+28.8%$494.9M-10.8%$514.3M-14.4%$555.0M$601.1M-2.5%$616.3M
Current Assets$483.2M+25.1%$385.8M-4.9%$386.1M-16.6%$405.5M$463.2M-2.6%$475.7M
Cash & Equivalents$87.1M+96.9%$86.2M-20.5%$44.3M-44.9%$108.4M$80.3M-24.9%$106.9M
Short-Term Investments$31.2M+74.2%$33.4M+75.9%$17.9M-7.9%$19.0M$19.4M$0
Inventory$62.3M+95.6%$35.0M+43.5%$31.9M+40.7%$24.4M$22.6M+18.7%$19.1M
Accounts ReceivableN/AN/AN/AN/AN/A$60.6M
Long-Term Investments$61.5M+2742.1%$2.0M-93.4%$2.2M-94.9%$30.3M$42.4M-40.3%$71.0M
Goodwill$3.7M+5.2%$3.6M$3.5MN/AN/AN/A
Total Liabilities$945.9M+25.8%$790.2M+5.5%$752.0M+4.7%$749.0M$718.6M+11.9%$642.0M
Current Liabilities$823.0M+17.8%$733.0M+17.0%$698.6M+17.7%$626.4M$593.7M+13.8%$521.9M
Non-Current Liabilities$122.9M+130.1%$57.2M-53.4%$53.4M-57.2%$122.7M$124.9M+3.9%$120.2M
Total Equity-$282.7M-17.9%-$293.7M-48.0%-$239.7M-84.7%-$198.5M-$129.8M-405.1%-$25.7M
Retained Earnings-$1.2B-5.9%-$1.2B-19.8%-$1.1B-19.7%-$996.4M-$939.5M-13.5%-$828.0M

Not reported in any period shown, so not listed: Long-Term Debt.

ECXWW Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

ECXWW quarterly cash flow statement
MetricQ4'2510-KQ2'2510-QQ4'2410-KQ2'2410-QQ4'2310-KQ4'2210-K

Not reported in any period shown, so not listed: Operating Cash Flow, Depreciation & Amortization, Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Investing Cash Flow, Financing Cash Flow, Dividends Paid, Share Buybacks.

ECXWW Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

ECXWW quarterly financial ratios
MetricQ4'2510-KQ2'2510-QQ4'2410-KQ2'2410-QQ4'2310-KQ4'2210-K
Current Ratio0.590.0x0.53-0.1x0.55-0.2x0.650.78-0.1x0.91

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Return on Equity, Return on Assets, Debt-to-Equity, Asset Turnover, FCF Margin.

Note: Shareholder equity is negative (-$282.7M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.59), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Frequently Asked Questions

What is Ecarx Holdings's annual revenue?

Ecarx Holdings (ECXWW) reported $847.9M in total revenue for fiscal year 2025. This represents a 9.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Ecarx Holdings's revenue growing?

Ecarx Holdings (ECXWW) revenue grew by 9.9% year-over-year, from $771.5M to $847.9M in fiscal year 2025.

Is Ecarx Holdings profitable?

No, Ecarx Holdings (ECXWW) reported a net income of -$66.0M in fiscal year 2025, with a net profit margin of -7.8%.

Ecarx Holdings (ECXWW) reported diluted earnings per share of -$0.20 for fiscal year 2025. This represents a 48.7% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Ecarx Holdings (ECXWW) had EBITDA of -$34.9M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

Ecarx Holdings (ECXWW) had a gross margin of 19.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Ecarx Holdings (ECXWW) had an operating margin of -6.5% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

Ecarx Holdings (ECXWW) had a net profit margin of -7.8% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Ecarx Holdings (ECXWW) recorded an outflow of $106.6M in free cash flow during fiscal year 2025. This represents a -40.4% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Ecarx Holdings (ECXWW) recorded an outflow of $94.4M in operating cash flow during fiscal year 2025, representing cash used by core business activities.

Ecarx Holdings (ECXWW) had $662.4M in total assets as of fiscal year 2025, including both current and long-term assets.

Ecarx Holdings (ECXWW) invested $12.2M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Ecarx Holdings (ECXWW) invested $123.3M in research and development during fiscal year 2025.

Ecarx Holdings (ECXWW) had a current ratio of 0.59 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

Ecarx Holdings (ECXWW) had a return on assets of -10.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Ecarx Holdings (ECXWW) has negative shareholder equity of -$282.7M as of fiscal year 2025, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

Ecarx Holdings (ECXWW) has a Piotroski F-Score of 2 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Ecarx Holdings (ECXWW) reported a net loss of $66.0M while operations used $94.4M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Ecarx Holdings (ECXWW) reported an operating loss of $54.8M against $23.8M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Back to top